In contrast Portis et al. [227] have demonstrated a Tax mediated functional inactivation of p53 in the early stage of the large granular lymphocytic tumor formation by the granzyme B-Tax transgene and p53-inactivating mutations in a later stage of the tumor progression. The gene discussed is CNTN2; the disease is neoplasm.